Trial Profile
A phase 2, double-blind, randomized, safety and efficacy study of GE-145 versus Iodixanol in subjects undergoing peripheral angiography.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Ioforminol (Primary) ; Iodixanol
- Indications Vascular disorders
- Focus Diagnostic use
- Sponsors Daiichi Sankyo Company
- 06 Jun 2016 New trial record